Inicio › Colitis ulcerativa › South Carolina
Ensayos clínicos de Colitis ulcerativa en South Carolina
12 estudios sobre Colitis ulcerativa buscan participantes en South Carolina.
Ciudades en South Carolina
Texto oficial del estudio (inglés)
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Palmetto Primary Care Physician Division of Gastroenterology, Summerville
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 30 sept 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Patewood Medical Campus /ID# 272477, Greenville
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 30 sept 2026 · NCT07071519A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0099, Charleston
ReclutandoFase 2/3
Edades de 2 a 17 · Todos los sexos · Actualizado el 24 sept 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Associates - Patewood, Greenville
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastroenterology Associates, P.A. of Greenville, Greenville
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Medical University of South Carolina, Charleston
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07415044An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Biocentric Health Research Partner, West Columbia
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 20 ago 2026 · NCT07184996BOOM-IBD2 Pivotal Clinical Trial
- Columbia Digestive Health Research (Objective Health), Columbia
Reclutando
Edades de 18 a 85 · Todos los sexos · Actualizado el 6 ago 2026 · NCT06571669A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Medical University of South Carolina, North Charleston
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 3 ago 2026 · NCT06100289An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Medical University of South Carolina (MUSC), Charleston
ReclutandoEstudio observacional
Edades de 18 a 64 · Todos los sexos · Actualizado el 9 jul 2026 · NCT06398626A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Medical University of South Carolina, Charleston
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 22 jun 2026 · NCT06405087A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Greenville
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.